Stay updated on Pembrolizumab in Advanced Adrenocortical Carcinoma Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab in Advanced Adrenocortical Carcinoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab in Advanced Adrenocortical Carcinoma Clinical Trial page

  1. Check
    6 days ago
    No Change Detected
  2. Check
    13 days ago
    No Change Detected
  3. Check
    20 days ago
    Change Detected
    Summary
    Added a PubMed auto-fill note clarifying that publications shown may be automatically filled from PubMed and may not all be about the study, and updated the revision to v3.3.2. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-11-25T10:51:38.000Z thumbnail image
  4. Check
    28 days ago
    Change Detected
    Summary
    Removed the government funding status banner that warned about updates and operating status. The banner previously appeared on the study page.
    Difference
    0.4%
    Check dated 2025-11-18T06:59:11.000Z thumbnail image
  5. Check
    42 days ago
    Change Detected
    Summary
    Both screenshots show no additions or deletions on the study details page; the layout and core sections remain unchanged.
    Difference
    0.4%
    Check dated 2025-11-03T21:05:17.000Z thumbnail image
  6. Check
    71 days ago
    Change Detected
    Summary
    Major update to page status and version: add operating-status notices and new version v3.2.0; remove a specific disease resource (Adrenal cortex carcinoma) and old version v3.1.0.
    Difference
    4%
    Check dated 2025-10-06T05:39:44.000Z thumbnail image
  7. Check
    78 days ago
    Change Detected
    Summary
    Changed the revision from v3.0.2 to v3.1.0, indicating a minor version update with no other content changes.
    Difference
    0.1%
    Check dated 2025-09-29T03:08:00.000Z thumbnail image
  8. Check
    92 days ago
    Change Detected
    Summary
    Updated to v3.0.2 and removed the Back to Top element; no core content or critical information is affected.
    Difference
    0.2%
    Check dated 2025-09-14T19:14:56.000Z thumbnail image

Stay in the know with updates to Pembrolizumab in Advanced Adrenocortical Carcinoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab in Advanced Adrenocortical Carcinoma Clinical Trial page.